{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T04:10:43Z","timestamp":1789099843002,"version":"build-2803163510"},"reference-count":35,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["PPA"],"DOI":"10.2147\/ppa.s421871","type":"journal-article","created":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T04:15:09Z","timestamp":1699244109000},"page":"2805-2819","source":"Crossref","is-referenced-by-count":9,"title":["Patient and Physician Preferences for Acute Myeloid Leukemia Maintenance Treatments Following Hematopoietic Stem Cell Transplantation"],"prefix":"10.2147","volume":"Volume 17","author":[{"given":"Lalit","family":"Saini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavik J","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasee V","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mo","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongbo","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7566-2813","authenticated-orcid":true,"given":"Yan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah A","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2023,11]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1002\/ajh.25620","volume":"94","author":"Molica","year":"2019","journal-title":"Am J Hematol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2425","DOI":"10.1200\/JCO.2011.38.9601","volume":"30","author":"Tefferi","year":"2012","journal-title":"J Clin Oncol"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"D\u00f6hner","year":"2017","journal-title":"Blood"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1182\/asheducation-2006.1.178","volume":"2006","author":"Small","year":"2006","journal-title":"Hematology"},{"key":"ref5","unstructured":"National Comprehensive Cancer Network\u00ae (NCCN). NCCN clinical practice guidelines in oncology. Acute Myeloid Leukemia. v1; 2022. Available from: https:\/\/www.nccn.org\/professionals\/physician_gls\/pdf\/aml.pdf. Accessed May 12, 2022."},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1922","DOI":"10.1007\/s12325-019-01003-7","volume":"36","author":"Pandya","year":"2019","journal-title":"Adv Ther"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"4373","DOI":"10.1158\/0008-5472.CAN-21-0301","volume":"81","author":"Cieri","year":"2021","journal-title":"Cancer Res"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"205","DOI":"10.4137\/CMO.S7244","volume":"6","author":"Lin","year":"2012","journal-title":"Clin Med Insights Oncol"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"997.e991","DOI":"10.1016\/j.jtct.2021.09.005","volume":"27","author":"Bewersdorf","year":"2021","journal-title":"Transplant Cell Ther"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1080\/0284186X.2021.1955969","volume":"260","author":"Pasvolsky","year":"2021","journal-title":"Acta Oncol"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2993","DOI":"10.1200\/JCO.19.03345","volume":"38","author":"Burchert","year":"2020","journal-title":"J Clin Oncol"},{"key":"ref12","unstructured":"Crenolanib maintenance following allogeneic stem cell transplantation in FLT3-positive acute myeloid leukemia patients. ClinicalTrials.gov identifier: NCT02400255. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02400255?term=NCT02400255&draw=2&rank=1. Accessed May 25, 2022."},{"key":"ref13","unstructured":"A trial of the FMS-like tyrosine kinase 3 (FLT3) inhibitor gilteritinib administered as maintenance therapy following allogeneic transplant for patients with FLT3\/internal tandem duplication (ITD) acute myeloid leukemia (AML). ClinicalTrials.gov identifier: NCT02997202. Available from: https:\/\/www.clinicaltrials.gov\/ct2\/show\/NCT02997202?term=gilteritinib+maintenance+AML&draw=4&rank=3. Accessed May 25, 2022."},{"key":"ref14","doi-asserted-by":"publisher","first-page":"S110","DOI":"10.1097\/00005650-198903001-00010","volume":"27","author":"Kaplan","year":"1989","journal-title":"Med Care"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"264","DOI":"10.2174\/1745017902117010264","volume":"17","author":"Morelli","year":"2021","journal-title":"Clin Pract Epidemiol Ment Health"},{"key":"ref16","first-page":"1423","volume":"152","author":"Stewart","year":"1995","journal-title":"Can Med Assoc J"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s13012-016-0480-9","volume":"11","author":"Elwyn","year":"2016","journal-title":"Implement Sci"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"e014719","DOI":"10.1136\/bmjopen-2016-014719","volume":"7","author":"Harrison","year":"2017","journal-title":"BMJ Open"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1136\/bmj.328.7436.360","volume":"328","author":"Ryan","year":"2004","journal-title":"BMJ"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1136\/bmj.320.7248.1530","volume":"320","author":"Ryan","year":"2000","journal-title":"BMJ"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.jval.2010.11.013","volume":"14","author":"Bridges","year":"2011","journal-title":"Value Health"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1016\/j.jval.2016.04.004","volume":"19","author":"Hauber","year":"2016","journal-title":"Value Health"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1007\/s40271-019-00401-x","volume":"13","author":"Hollin","year":"2020","journal-title":"Patient"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jval.2012.08.2223","volume":"16","author":"Reed Johnson","year":"2013","journal-title":"Value Health"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1002\/hec.1739","volume":"21","author":"Coast","year":"2012","journal-title":"Health Econ"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1258\/135581907779497602","volume":"12","author":"Coast","year":"2007","journal-title":"J Health Serv Res Policy"},{"key":"ref27","unstructured":"Johnson R, Orme B Getting the most from CBC. Sequim: Sawtooth Software Research Paper Series, Sawtooth Software; 2003."},{"key":"ref28","doi-asserted-by":"publisher","first-page":"249","DOI":"10.2165\/11539650-000000000-00000","volume":"3","author":"Marshall","year":"2010","journal-title":"Patient"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1080\/14737167.2017.1389648","volume":"17","author":"Janssen","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"ref30","unstructured":"EuroQol Research Foundation. EQ-5D-5L User Guide; 2019. Available from: https:\/\/euroqol.org\/publications\/user-guides. Accessed May 26, 2022."},{"key":"ref31","unstructured":"Reilly Associates. WPAI Scoring. Available from: http:\/\/www.reillyassociates.net\/WPAI_Scoring.html. Accessed May 26, 2022."},{"key":"ref32","doi-asserted-by":"publisher","first-page":"942","DOI":"10.1158\/1055-9965.EPI-19-1277","volume":"29","author":"Richardson","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref33","doi-asserted-by":"publisher","first-page":"2843","DOI":"10.2217\/fon-2022-0378","volume":"18","author":"Batchelder","year":"2022","journal-title":"Future Oncol"},{"key":"ref34","doi-asserted-by":"publisher","first-page":"2075","DOI":"10.2217\/fon-2022-0082","volume":"18","author":"Ashaye","year":"2022","journal-title":"Future Oncol"},{"key":"ref35","doi-asserted-by":"crossref","unstructured":"Griffin J, Shah M, Song Y, Yang H, Tang W Economic burden of relapse after hematopoietic stem cell transplantation (HSCT) in patients with acute myeloid leukemia (AML)- a retrospective claims-based analysis. Paper presented at: ISPOR Europe. November 2\u20136; 2019; Copenhagen, Denmark.","DOI":"10.1016\/j.jval.2019.09.364"}],"container-title":["Patient Preference and Adherence"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94038","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=94038","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,6]],"date-time":"2023-11-06T04:15:12Z","timestamp":1699244112000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/patient-and-physician-preferences-for-acute-myeloid-leukemia-maintenan-peer-reviewed-fulltext-article-PPA"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11]]},"references-count":35,"URL":"https:\/\/doi.org\/10.2147\/ppa.s421871","relation":{},"ISSN":["1177-889X"],"issn-type":[{"value":"1177-889X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11]]}}}